Reactive community-based self-administered treatment against residual malaria transmission: study protocol for a randomized controlled trial.
Reactive community-based self-administered treatment against residual malaria transmission: study protocol for a randomized controlled trial.
复制标题
DOI：
10.1186/s13063-018-2506-x
复制
发表时间：
2018-02-20
期刊：
影响因子：
2.5
通讯作者：
D'Alessandro U
中科院分区：
文献类型：
--
作者：
Okebe J;Ribera JM;Balen J;Jaiteh F;Masunaga Y;Nwakanma D;Bradley J;Yeung S;Peeters Grietens K;D'Alessandro U
Systematic treatment of all individuals living in the same compound of a clinical malaria case may clear asymptomatic infections and possibly reduce malaria transmission, where this is focal. High and sustained coverage is extremely important and requires active community engagement. This study explores a community-based approach to treating malaria case contacts. This is a cluster-randomized trial to determine whether, in low-transmission areas, treating individuals living in the same compound of a clinical malaria case with dihydroartemisinin-piperaquine can reduce parasite carriage and thus residual malaria transmission. Treatment will be administered through the local health system with the approach of encouraging community participation designed and monitored through formative research. The trial goal is to show that this approach can reduce in intervention villages the prevalence of Plasmodium falciparum infection toward the end of the malaria transmission season. Adherence and cooperation of the local communities are critical for the success of mass treatment campaigns aimed at reducing malaria transmission. By exploring community perceptions of the changing trends in malaria burden, existing health systems, and reaction to self-administered treatment, this study will develop and adapt a model for community engagement toward malaria elimination that is cost-effective and fits within the existing health system. Clinical trials.gov, NCT02878200. Registered on 25 August 2016. The online version of this article (10.1186/s13063-018-2506-x) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子：
3
作者：
Tiono, Alfred B.;Ouedraogo, Alphonse;Hamed, Kamal
通讯作者：
Hamed, Kamal
影响因子：
3
作者：
Tynan, Anna;Atkinson, Jo-An;Vallely, Andrew
通讯作者：
Vallely, Andrew
影响因子：
3.7
作者：
Dierickx S;Gryseels C;Mwesigwa J;O'Neill S;Bannister-Tyrell M;Ronse M;Jaiteh F;Gerrets R;D'Alessandro U;Grietens KP
通讯作者：
Grietens KP
影响因子：
168.9
作者：
Kaneko, A;Taleo, G;Björkman, A
通讯作者：
Björkman, A
影响因子：
4
作者：
Carter, Ben R.;Hood, Kerenza
通讯作者：
Hood, Kerenza